IHS Chemical Week

People & Business :: People/Executives

Merck KGaA announces multiple management changes in its pharmaceutical businesses

8:00 AM MDT | September 26, 2013 | Deepti Ramesh

Merck KGaA (Darmstadt, Germany) today announced multiple management and organizational changes in its pharmaceutical businesses. Belén Garijo, currently COO at Merck Serono (Geneva), the biopharmaceutical division of Merck KGaA, has been appointed president and CEO of Merck Serono, effective 1 October. She will succeed Stefan Oschmann, who, as member of the executive board and head/pharmaceuticals at Merck, will focus on further developing the Merck Serono and consumer health divisions as well as the allergopharma and biosimilars units. All four...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa